*Result*: Constructing a screening model to identify patients at high risk of hospital-acquired influenza on admission to hospital.
BMJ. 2024 Jan 8;384:e074819. (PMID: 38191193)
BMC Med Res Methodol. 2023 Oct 25;23(1):249. (PMID: 37880592)
Int J Mol Sci. 2023 Jul 13;24(14):. (PMID: 37511165)
BMC Infect Dis. 2024 May 2;24(1):466. (PMID: 38698304)
J Med Virol. 2020 Aug;92(8):1047-1052. (PMID: 31825110)
J Hosp Infect. 2024 Apr;146:232-241. (PMID: 38029857)
J Hosp Infect. 2023 Sep;139:134-140. (PMID: 37419188)
Nature. 2025 Jan;637(8045):319-326. (PMID: 39780007)
Infect Dis Poverty. 2023 Nov 13;12(1):99. (PMID: 37953290)
J Hosp Infect. 2019 Jan;101(1):30-37. (PMID: 29909095)
Genome Biol. 2021 Sep 20;22(1):271. (PMID: 34544450)
Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):15849-15854. (PMID: 31341078)
Enferm Infecc Microbiol Clin (Engl Ed). 2023 Aug-Sep;41(7):391-395. (PMID: 36064786)
BMC Infect Dis. 2020 Nov 19;20(1):863. (PMID: 33213361)
JAMA Netw Open. 2023 Jul 3;6(7):e2322285. (PMID: 37418262)
Infect Control Hosp Epidemiol. 2022 Oct;43(10):1447-1453. (PMID: 34607624)
PLoS One. 2024 Feb 28;19(2):e0299488. (PMID: 38416761)
J Clin Virol. 2015 Dec;73:47-51. (PMID: 26540462)
Nat Med. 2023 Jul;29(7):1804-1813. (PMID: 37386246)
Sci Rep. 2021 Feb 3;11(1):2886. (PMID: 33536462)
Medicine (Baltimore). 2021 Mar 19;100(11):e25142. (PMID: 33725996)
Phys Med Biol. 2018 Mar 29;63(7):07TR01. (PMID: 29512515)
BMJ. 2020 Mar 18;368:m441. (PMID: 32188600)
Eur Radiol. 2023 Jul;33(7):4801-4811. (PMID: 36719494)
Int J Surg. 2025 Jan 01;111(1):791-806. (PMID: 39037718)
Travel Med Infect Dis. 2024 Jan-Feb;57:102676. (PMID: 38061408)
BMC Infect Dis. 2020 Jan 28;20(1):80. (PMID: 31992207)
Clin Infect Dis. 2020 Dec 3;71(9):e377-e383. (PMID: 32011654)
Nat Biomed Eng. 2018 Oct;2(10):749-760. (PMID: 31001455)
Am J Infect Control. 2021 Aug;49(8):1066-1071. (PMID: 33321130)
Front Public Health. 2024 Jan 05;11:1300228. (PMID: 38249383)
J Infect Public Health. 2022 Oct;15(10):1118-1123. (PMID: 36137361)
Br J Cancer. 2024 Sep;131(4):692-701. (PMID: 38918556)
*Further Information*
*Objective: To develop a machine learning (ML)-based admission screening model for hospital-acquired (HA) influenza using routinely available data to support early clinical intervention.
Methods: The study focused on hospitalized patients from January 2021 to May 2024. The case group consisted of patients with HA influenza, while the control group comprised non-HA influenza patients admitted to the same ward in the HA influenza unit within 2 weeks. The 953 subjects were divided into the training set and the validation set in a 7:3 ratio. Feature screening was performed using least absolute shrinkage and selection operator (LASSO) and the Boruta algorithm. Subsequently eight ML algorithms were applied to analyze and identify the optimal model using a 5-fold cross-validation methodology. And the area under the curve (AUC), area under the precision-recall curve (AP), F1 score, calibration curve and decision curve analysis (DCA) were applied to comprehensively assess the predictive effectiveness of the selected models. Feature factors were selected and feature importance's were assessed using SHapley's additive interpretation (SHAP). Furthermore, an interactive web-based platform was additionally developed to visualize and demonstrate the predictive model.
Results: Age, pneumonia on admission, Chronic renal failure, Malignant tumor, hypoproteinemia, glucocorticoid use, admission to ICU, lymphopenia, BMI were identified as key variables. For the eight ML algorithms, ROC values ranging from 0.548 to 0.812 were observed in the validation set. A comprehensive analysis showed that the XGBoost model predicted the highest accuracy (AUC: 0.812) with an F1 score of 0.590 and the highest A p value (0.655). Evaluating the optimal model, the AUC values were 0.995, 0.826, and 0.781 for the training, validation and test sets. The XGBoost model showed strong robust. SHapley's additive interpretation (SHAP) was utilized to analyze the contribution of explanatory variables to the model and their correlation with HA influenza. In addition, we developed a practical online prediction tool to calculate the risk of HA influenza occurrence.
Conclusion: Based on the routine data, the XGBoost model demonstrated excellent calibration among all ML algorithms and accurately predicted the risk of HA influenza, thereby serving as an effective tool for early screening of HA influenza.
(Copyright © 2025 Zhang, Li, Qiao, Qin, Wu and Guo.)*
*The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.*